Click here to view the Humana Medical Policy Updates Updates » September 2024 Humana Medical…
BCBS North Carolina Medical Policy Updates – May 2018
Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »
May 2018 Medical Policy Updates:
- Allergy Testing
- Allogeneic Hematopoietic Transplant for Genetic Diseases and Acquired Anemia
- Ambulatory Event Monitors
- Analysis of MGMT Promoter Methylation in Malignant Gliomas
- Assays of Genetic Expression to Determine Prognosis of Breast Cancer
- Baroreflex Stimulation Devices
- BRAF Gene Mutation Testing to Select Melanoma or Glioma Patients for Targeted Therapy
- Brentuximab Vedotin (Adcetris®)
- Circulating Tumor DNA for Cancer Management (Liquid Biopsy)
- Denosumab (ProliaTM, XGEVATM)
- Drug Testing in Pain Management and Substance Abuse Treatment
- Eculizumab (Soliris®)
- Enhanced External Counterpulsation (EECP)
- Eribulin Mesylate (Halaven®)
- External Defibrillators
- Gene Expression Testing in the Evaluation of Patients With Stable Ischemic Heart Disease
- Genetic Cancer Susceptibility Panels Using Next Generation Sequencing
- Genetic Testing for Cardiac Ion Channelopathies
- Golimumab (Simponi Aria)
- Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia
- Hematopoietic Stem-Cell Transplantation for Acute Myeloid Leukemia
- Immunoglobulin Therapy
- In Vitro Chemoresistance and Chemosensitivity Assays
- Infliximab, Infliximab-dyyb, Infliximab-abda
- Infusion Therapy in the Home
- Intradialytic Parenteral Nutrition
- Laboratory Tests for Heart Transplant Rejection
- Lipid Apheresis
- Monoclonal Antibodies for Non-Hodgkin Lymphoma and Acute Myeloid Leukemia In the Non-Hematopoietic Stem Cell Transplant Setting
- Monoclonal Antibody Imaging for Prostate Cancer
- Multigene Expression Assay for Predicting Recurrence in Colon Cancer
- Proteomic Testing for Targeted Therapy in Non-Small Cell Lung Cancer
- Radiofrequency Ablation of the Renal Nerves as a Treatment of Hypertension
- Renal (Kidney) Transplantation
- Serum Biomarker Human Epididymis Protein 4 (HE4)
- ST2 Assay for Chronic Heart Failure
- Surgical Management of Transcatheter Heart Valves
- Synthetic Cartilage Implants for Joint Pain
Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.